
Expanding into France and Germany is a major opportunity—but also one of the biggest challenges in digital health.
Different reimbursement systems. Complex regulations. Fragmented buyer landscapes. Many startups enter too early or with the wrong positioning.
This program is built to change that.
The Go-To-Market Program supports international digital health startups in understanding, navigating, and validating their approach to scale in Europe. Through a structured, one-year journey, the program supports healthtech startups to develop a clear, execution-ready market access strategy tailored to France and Germany.

Founded by Capgemini, Generali, Orange and Sanofi in 2021, Future4care is a launchpad for visionary healthcare startups. Today, it brings together 100+ partners and startups in a thriving ecosystem dedicated to digital health innovation.
The Go To Market Program is a one-year hybrid journey combining four in-person sessions with monthly mentoring, hands-on workshops, and targeted working sessions to build, test, and refine your market access strategy. Each in-person meeting is anchored to major European health events.
How does it work?
Structured across key phases, the program takes you from product-market fit and positioning into market validation and use case development, before focusing on healthcare systems integration, regulatory and reimbursement pathways. We also cover clinical validation and fundraising strategies.
Along the way, selected startups will:
Develop and stress-test your market access strategy
Map key stakeholders and partnership opportunities
Adapt their positioning to France and Germany
Strengthen their storytelling for different audiences, including investors and potential partners
All continuously validated through real-world feedback and ecosystem exposure.
We are looking for Seed to Series B startups ready to strengthen their strategy and scale in healthcare in the following verticals:
Optimizing the healthcare value chain through AI-driven discovery, precision medicine, and clinical trial data synthesis.
Scaling digital therapeutics (DTx) and predictive analytics to shift the paradigm from reactive to proactive care.
Deploying clinical decision-support and automated resource management to drive institutional operational excellence.
Implementing advanced longevity models, from assistive robotics to cognitive health platforms for independent living.
Entering France and Germany requires more than a generic expansion plan. This program is designed to help startpus get it right.
Built for healthcare system complexity
Tailored specifically for the nuances of EU healthcare. Navigate reimbursement, regulation, and system fragmentation with a tailored approach.
Focused on strategy and execution
Move beyond theory into real-world strategy stress-testing. Startups will actively build, test, and refine their market access strategy, not just learn about it.


Continuous Validation
Your positioning, use cases, and assumptions are continuously challenged through structured feedback and real-world insights.
From clarity to readiness
Move forward with a clear strategy and a stronger foundation for scaling and fundraising.
Program details
€6,000 + VAT (Equity-Free). Includes access to our Paris and Berlin offices, and a high-impact showcase during our 2027 Demo Day.
APPLICATION PERIOD
Apply early (before June 10th, 2026) for priority review and early program benefits. The application process is simple and fast.
ONGOING APPLICATION REVIEW
Applications are reviewed on a rolling basis, with priority given to those submitted before June 10th, 2026.
INTERVIEW & PITCH
Shortlisted startups will present their solution and vision to a panel of experts from our corporate founders and team.
PROGRAM KICK-OFF
The program begins on September 2026 with a virtual kick-off and continues with the first in-person meeting a few weeks later at a high-level European conference in Berlin.
By applying to the Go To Market Program organized by Future4care, you agree to the program’s terms and conditions, eligibility, and details. Get ready to scale and innovate in Europe's healthcare markets.